Clinical trials
Completed Respiratory Distress Syndrome trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 2 |
| 2017 | 1 |
| 2019 | 2 |
| 2020 | 7 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 29 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hospital Universitario de Gran Canaria Doctor Negrín | 5 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Banc de Sang i Teixits | 1 |
| Biotest | 1 |
| Boehringer Ingelheim | 1 |
| Complejo Hospitalario Universitario de Albacete | 1 |
| Consorcio Centro de Investigación Biomédica en Red (CIBER) | 1 |
| Cristina Avendaño Solá | 1 |
| Debiopharm International SA | 1 |
| Eli Lilly and Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Respiratory Distress Syndrome | 29 |
| Acute Lung Injury | 6 |
| COVID-19 | 6 |
| Respiratory Insufficiency | 4 |
| Pneumonia | 3 |
| Bronchial Spasm | 1 |
| Community-Acquired Pneumonia | 1 |
| Coronavirus Infections | 1 |
| Cytokine Release Syndrome | 1 |
| Fibrosis | 1 |
Trials
Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.